• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clinical, biomarker, and genetic predictors of specific types of atrial fibrillation in a community-based cohort: data of the PREVEND study.基于社区队列的特定类型心房颤动的临床、生物标志物和遗传预测因子:PREVEND 研究的数据。
Europace. 2017 Feb 1;19(2):226-232. doi: 10.1093/europace/euw016.
2
Systematic review on urine albumin testing for early detection of diabetic complications.关于尿白蛋白检测用于早期发现糖尿病并发症的系统评价。
Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. doi: 10.3310/hta9300.
3
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
4
Systematic screening for the detection of atrial fibrillation.用于检测心房颤动的系统筛查。
Cochrane Database Syst Rev. 2016 Jun 3;2016(6):CD009586. doi: 10.1002/14651858.CD009586.pub3.
5
Polygenic risk-based prediction of heart failure in young patients with atrial fibrillation: an analysis from UK Biobank.基于多基因风险的年轻房颤患者心力衰竭预测:来自英国生物银行的分析。
Europace. 2025 Jul 1;27(7). doi: 10.1093/europace/euaf104.
6
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
7
Genetic Interactions with Age, Sex, Body Mass Index, and Hypertension in Relation to Atrial Fibrillation: The AFGen Consortium.遗传因素与年龄、性别、体重指数和高血压在心房颤动中的相互关系:AFGen 联盟。
Sci Rep. 2017 Sep 12;7(1):11303. doi: 10.1038/s41598-017-09396-7.
8
Relation of N-terminal pro-brain natriuretic peptide and new-onset atrial fibrillation in patients with acute coronary syndrome: a systematic review and meta-analysis.急性冠脉综合征患者中N端前脑钠肽与新发房颤的关系:一项系统评价和荟萃分析
Scand J Clin Lab Invest. 2016 Oct;76(6):460-4. doi: 10.1080/00365513.2016.1199048. Epub 2016 Jun 27.
9
Mechanistic Pathways Underlying Genetic Predisposition to Atrial Fibrillation Are Associated With Different Cardiac Phenotypes and Cardioembolic Stroke Risk.心房颤动遗传易感性的潜在机制途径与不同的心脏表型和心源性卒中风险相关。
Circ Genom Precis Med. 2025 Jun;18(3):e004932. doi: 10.1161/CIRCGEN.124.004932. Epub 2025 Jun 17.
10
Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.心房颤动和典型心房扑动的根治性导管消融术:系统评价与经济评估
Health Technol Assess. 2008 Nov;12(34):iii-iv, xi-xiii, 1-198. doi: 10.3310/hta12340.

引用本文的文献

1
Dynamic evaluation of atrial fibrillation risk factors using multiple sensors of implantable cardioverter defibrillators.使用植入式心脏复律除颤器的多个传感器对房颤危险因素进行动态评估。
Int J Cardiol Heart Vasc. 2025 Jun 20;59:101731. doi: 10.1016/j.ijcha.2025.101731. eCollection 2025 Aug.
2
Generative artificial intelligence for general practice; new potential ahead, but are we ready?用于全科医疗的生成式人工智能:前景可期,但我们准备好了吗?
Eur J Gen Pract. 2025 Dec;31(1):2511645. doi: 10.1080/13814788.2025.2511645. Epub 2025 Jun 6.
3
Hospitalizations of Patients with Atrial Fibrillation (AF) in Poland: A Nationwide Study Based on over One Million AF Hospitalizations in 2017-2021.波兰心房颤动(AF)患者的住院情况:一项基于2017 - 2021年超过100万例AF住院病例的全国性研究。
J Clin Med. 2024 Nov 2;13(21):6592. doi: 10.3390/jcm13216592.
4
Editorial: Pharmacological therapy in patients with arrhythmias.社论:心律失常患者的药物治疗
Front Pharmacol. 2024 Jul 25;15:1465539. doi: 10.3389/fphar.2024.1465539. eCollection 2024.
5
Atrial Fibrillation, Atrial Myopathy, and Thromboembolism: The Additive Value of Echocardiography and Possible New Horizons for Risk Stratification.心房颤动、心房肌病与血栓栓塞:超声心动图的附加价值及风险分层的可能新视野
J Clin Med. 2024 Jul 4;13(13):3921. doi: 10.3390/jcm13133921.
6
Aggressive Rhythm Control Strategy in Atrial Fibrillation Patients Presenting at the Emergency Department: The HEROMEDICUS Study Design and Initial Results.急诊科房颤患者的积极节律控制策略:HEROMEDICUS研究设计与初步结果
J Cardiovasc Dev Dis. 2024 Mar 31;11(4):109. doi: 10.3390/jcdd11040109.
7
Impact of atrial fibrillation on 1-year outcome in patients with implantable cardioverter defibrillator or cardiac resynchronization therapy with defibrillator: results from the German DEVICE Registry.心房颤动对植入式心脏复律除颤器或心脏再同步化治疗除颤器患者1年预后的影响:来自德国DEVICE注册研究的结果
J Thorac Dis. 2024 Mar 29;16(3):1825-1835. doi: 10.21037/jtd-23-274. Epub 2024 Mar 27.
8
Association between weight loss and outcomes in patients undergoing atrial fibrillation ablation: a systematic review and dose-response meta-analysis.体重减轻与房颤消融患者预后之间的关联:一项系统评价和剂量反应荟萃分析。
Nutr Metab (Lond). 2023 Jan 31;20(1):5. doi: 10.1186/s12986-023-00724-5.
9
Atrial fibrillation patterns and their cardiovascular risk profiles in the general population: the Rotterdam study.一般人群中心房颤动的模式及其心血管风险特征:鹿特丹研究。
Clin Res Cardiol. 2023 Jun;112(6):736-746. doi: 10.1007/s00392-022-02071-6. Epub 2022 Aug 10.
10
Molecular Insights in Atrial Fibrillation Pathogenesis and Therapeutics: A Narrative Review.心房颤动发病机制与治疗的分子见解:一篇叙述性综述
Diagnostics (Basel). 2021 Aug 31;11(9):1584. doi: 10.3390/diagnostics11091584.

本文引用的文献

1
Incidence of Atrial Fibrillation and Relationship With Cardiovascular Events, Heart Failure, and Mortality: A Community-Based Study From the Netherlands.心房颤动的发生率及其与心血管事件、心力衰竭和死亡率的关系:来自荷兰的一项基于社区的研究。
J Am Coll Cardiol. 2015 Sep 1;66(9):1000-7. doi: 10.1016/j.jacc.2015.06.1314.
2
Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES.根据房颤模式评估缺血性卒中风险:ACTIVE-A 和 AVERROES 中 6563 例阿司匹林治疗患者的分析。
Eur Heart J. 2015 Feb 1;36(5):281-7a. doi: 10.1093/eurheartj/ehu307. Epub 2014 Sep 3.
3
Genetic determinants of P wave duration and PR segment.P波时限和PR段的遗传决定因素。
Circ Cardiovasc Genet. 2014 Aug;7(4):475-81. doi: 10.1161/CIRCGENETICS.113.000373. Epub 2014 May 21.
4
Predisposing factors associated with development of persistent compared with paroxysmal atrial fibrillation.与阵发性心房颤动相比,与持续性心房颤动发生相关的 predisposing 因素。 注:“predisposing”常见释义为“使易患;使倾向于” ,这里直接保留英文未翻译,因为在医学语境中可能有特定专业含义,需结合上下文准确理解,若没有更多背景信息,直接翻译可能影响专业性和准确性。 你可根据实际情况进一步完善。
J Am Heart Assoc. 2014 May 1;3(3):e000916. doi: 10.1161/JAHA.114.000916.
5
Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study.全球心房颤动流行病学:2010 年全球疾病负担研究。
Circulation. 2014 Feb 25;129(8):837-47. doi: 10.1161/CIRCULATIONAHA.113.005119. Epub 2013 Dec 17.
6
Atrial fibrillation patterns and risks of subsequent stroke, heart failure, or death in the community.社区中房颤模式与后续卒中、心力衰竭或死亡的风险。
J Am Heart Assoc. 2013 Sep 3;2(5):e000126. doi: 10.1161/JAHA.113.000126.
7
Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference.心房颤动的个体化管理:第四届心房颤动能力网络/欧洲心律协会共识会议记录。
Europace. 2013 Nov;15(11):1540-56. doi: 10.1093/europace/eut232. Epub 2013 Aug 27.
8
Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060.欧盟心房颤动患者数量预测,从 2000 年至 2060 年。
Eur Heart J. 2013 Sep;34(35):2746-51. doi: 10.1093/eurheartj/eht280. Epub 2013 Jul 30.
9
Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND.基于社区队列的射血分数保留与降低的心衰患者新发心衰的发病率和流行病学:PREVEND 的 11 年随访研究。
Eur Heart J. 2013 May;34(19):1424-31. doi: 10.1093/eurheartj/eht066. Epub 2013 Mar 6.
10
Meta-analysis identifies six new susceptibility loci for atrial fibrillation.荟萃分析确定了六个心房颤动的新易感性位点。
Nat Genet. 2012 Apr 29;44(6):670-5. doi: 10.1038/ng.2261.

基于社区队列的特定类型心房颤动的临床、生物标志物和遗传预测因子:PREVEND 研究的数据。

Clinical, biomarker, and genetic predictors of specific types of atrial fibrillation in a community-based cohort: data of the PREVEND study.

机构信息

Department of Cardiology, University of Groningen, University Medical Center Groningen, PO Box 30.001, 9700 RB Groningen, The Netherlands.

出版信息

Europace. 2017 Feb 1;19(2):226-232. doi: 10.1093/europace/euw016.

DOI:10.1093/europace/euw016
PMID:28175276
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5834149/
Abstract

AIMS

Atrial fibrillation (AF) may present variously in time, and AF may progress from self-terminating to non-self-terminating AF, and is associated with impaired prognosis. However, predictors of AF types are largely unexplored. We investigate the clinical, biomarker, and genetic predictors of development of specific types of AF in a community-based cohort.

METHODS

We included 8042 individuals (319 with incident AF) of the PREVEND study. Types of AF were compared, and multivariate multinomial regression analysis determined associations with specific types of AF.

RESULTS

Mean age was 48.5 ± 12.4 years and 50% were men. The types of incident AF were ascertained based on electrocardiograms; 103(32%) were classified as AF without 2-year recurrence, 158(50%) as self-terminating AF, and 58(18%) as non-self-terminating AF. With multivariate multinomial logistic regression analysis, advancing age (P< 0.001 for all three types) was associated with all AF types, male sex was associated with AF without 2-year recurrence and self-terminating AF (P= 0.031 and P= 0.008, respectively). Increasing body mass index and MR-proANP were associated with both self-terminating (P= 0.009 and P< 0.001) and non-self-terminating AF (P= 0.003 and P< 0.001). The only predictor associated with solely self-terminating AF is prescribed anti-hypertensive treatment (P= 0.019). The following predictors were associated with non-self-terminating AF; lower heart rate (P= 0.018), lipid-lowering treatment prescribed (P= 0.009), and eGFR <60 mL/min/1.73 m2 (P= 0.006). Three known AF-genetic variants (rs6666258, rs6817105, and rs10821415) were associated with self-terminating AF.

CONCLUSIONS

We found clinical, biomarker and genetic predictors of specific types of incident AF in a community-based cohort. The genetic background seems to play a more important role than modifiable risk factors in self-terminating AF.

摘要

目的

心房颤动(AF)可能在不同时间出现,AF 可能从自行终止转变为非自行终止 AF,并与预后不良有关。然而,AF 类型的预测因素在很大程度上尚未得到探索。我们在一个基于社区的队列中研究了临床、生物标志物和遗传因素对特定类型 AF 发展的预测作用。

方法

我们纳入了 PREVEND 研究中的 8042 名个体(319 名发生 AF)。比较了 AF 的类型,并通过多变量多项逻辑回归分析确定了与特定类型 AF 的关联。

结果

平均年龄为 48.5±12.4 岁,50%为男性。根据心电图确定了新发 AF 的类型;103 例(32%)被归类为无 2 年复发的 AF,158 例(50%)为自行终止的 AF,58 例(18%)为非自行终止的 AF。通过多变量多项逻辑回归分析,年龄增长(所有三种类型的 P<0.001)与所有 AF 类型相关,男性与无 2 年复发和自行终止的 AF 相关(P=0.031 和 P=0.008)。体重指数和 MR-proANP 的增加与自行终止(P=0.009 和 P<0.001)和非自行终止的 AF 相关(P=0.003 和 P<0.001)。唯一与单纯自行终止的 AF 相关的预测因素是处方抗高血压治疗(P=0.019)。与非自行终止的 AF 相关的预测因素包括:心率较低(P=0.018)、处方降脂治疗(P=0.009)和 eGFR<60 mL/min/1.73 m2(P=0.006)。三种已知的 AF 遗传变异(rs6666258、rs6817105 和 rs10821415)与自行终止的 AF 相关。

结论

我们在一个基于社区的队列中发现了特定类型新发 AF 的临床、生物标志物和遗传预测因素。遗传背景在自行终止的 AF 中似乎比可改变的危险因素发挥更重要的作用。